Enhanced Sensitivity of the MRL/MpJ Mouse to the Neuroplastic and Behavioral Effects of Chronic Antidepressant Treatments
Open Access
- 28 January 2009
- journal article
- research article
- Published by Springer Science and Business Media LLC in Neuropsychopharmacology
- Vol. 34 (7), 1764-1773
- https://doi.org/10.1038/npp.2008.234
Abstract
Chronic administration of antidepressant drugs produce changes in neuroplasticity and behavior in rodents, effects that may be associated with the slow emergence of clinical therapeutic effects. Owing to the uncertainty over the effects of chronic antidepressant treatments in mice, these experiments compared the regulation of neurogenesis, neurotrophin levels, and behavior produced by chronic antidepressant treatments between two inbred mouse strains, MRL/MpJ and C57BL/6J. The MRL/MpJ strain is associated with enhanced wound healing and tissue regeneration, whereas C57BL/6J mice are used commonly for behavioral studies. Proliferation and survival of hippocampal progenitor cells were measured using flow cytometry, a new platform that rapidly quantifies the incorporation of 5-bromo-2-deoxyuridine (BrdU). Hippocampal cell proliferation was increased significantly after chronic administration of fluoxetine (FLX: 5, 10 mg/kg, intraperitoneal (i.p.), b.i.d.) or desipramine (DMI: 5, 10 mg/kg, i.p., b.i.d.) for 21 days in MRL/MpJ mice, but not in C57BL/6J mice. Hippocampal progenitor cells born prior to chronic antidepressant treatments were not affected in either mouse strain. Protein levels of brain-derived neurotrophic factor (BDNF) in MRL/MpJ mice were elevated significantly in the frontal cortex, hippocampus, and amygdala after chronic FLX treatment, but increased only in the frontal cortex by chronic DMI. In contrast, BDNF levels in C57BL/6J mice were decreased in the hippocampus and increased in the amygdala after chronic FLX, and were decreased in the brain stem after chronic DMI. Novelty-induced hypophagia (NIH) was used to examine a behavioral effect produced by chronic antidepressant treatment. MRL/MpJ mice, chronically administered FLX or DMI, had significantly shorter latencies to consume food when exposed to a novel environment than untreated mice, whereas there were no effects on the behavior of C57BL/6J mice. In conclusion, robust effects of chronic antidepressant treatments on hippocampal cell proliferation and BDNF levels paralleled the ability of these drugs to produce changes in NIH behavior in MRL/MpJ, while none of these effects were produced in C57BL/6J mice. The greater responsiveness of MRL/MpJ mice may be important for drug discovery, for genetic studies, and for understanding the neural mechanisms underlying the physiological and behavioral effects of chronic antidepressant treatments.Keywords
This publication has 48 references indexed in Scilit:
- Flow cytometric analysis of BrdU incorporation as a high-throughput method for measuring adult neurogenesis in the mouseJournal of Pharmacological and Toxicological Methods, 2009
- Adult hippocampal neurogenesis: Regulation, functional implications, and contribution to disease pathologyNeuroscience & Biobehavioral Reviews, 2008
- Antidepressant drug‐induced stimulation of mouse hippocampal neurogenesis is age‐dependent and altered by early life stressJournal of Comparative Neurology, 2008
- Differential regulation of central BDNF protein levels by antidepressant and non-antidepressant drug treatmentsBrain Research, 2008
- Changes in adult neurogenesis in neurodegenerative diseases: cause or consequence?Genes, Brain and Behavior, 2008
- Neurogenesis and Helplessness Are Mediated by Controllability in Males But Not in FemalesBiological Psychiatry, 2007
- Discovery of Novel Hippocampal Neurogenic Agents by Using an in Vivo Stable Isotope Labeling TechniqueJournal of Pharmacology and Experimental Therapeutics, 2006
- Neuroblast protuberances in the subventricular zone of the regenerative MRL/MpJ mouseJournal of Comparative Neurology, 2006
- Fluoxetine targets early progenitor cells in the adult brainProceedings of the National Academy of Sciences, 2006
- Cannabinoids promote embryonic and adult hippocampus neurogenesis and produce anxiolytic- and antidepressant-like effectsJCI Insight, 2005